Free Trial

CME Group Inc. $CME Shares Sold by USS Investment Management Ltd

CME Group logo with Finance background

Key Points

  • USS Investment Management Ltd reduced its stake in CME Group Inc. by 42.0%, owning 59,820 shares valued at approximately $15.87 million after selling 43,300 shares in the first quarter.
  • CME Group recently announced a quarterly dividend of $1.25 per share, resulting in an annualized yield of 1.9%, with the payout date set for September 25th.
  • The stock of CME Group is currently trading at around $261.94, down 2.1%, and has a market capitalization of $94.40 billion.
  • MarketBeat previews the top five stocks to own by October 1st.

USS Investment Management Ltd lowered its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 42.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,820 shares of the financial services provider's stock after selling 43,300 shares during the period. USS Investment Management Ltd's holdings in CME Group were worth $15,866,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Wayfinding Financial LLC acquired a new stake in CME Group in the 1st quarter valued at $25,000. Cornerstone Planning Group LLC grew its stake in shares of CME Group by 122.2% in the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after buying an additional 55 shares in the last quarter. Golden State Wealth Management LLC raised its holdings in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after buying an additional 98 shares during the period. Alpine Bank Wealth Management acquired a new position in CME Group during the 1st quarter worth approximately $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new position in CME Group in the 1st quarter worth approximately $32,000. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Transactions at CME Group

In other news, Director William R. Shepard bought 256 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was bought at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director owned 258,196 shares in the company, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles P. Carey sold 500 shares of CME Group stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the completion of the transaction, the director owned 4,900 shares of the company's stock, valued at approximately $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.

CME Group Stock Down 2.1%

CME stock opened at $261.94 on Friday. The company has a market capitalization of $94.40 billion, a P/E ratio of 25.36, a PEG ratio of 4.74 and a beta of 0.43. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a twelve month low of $212.38 and a twelve month high of $290.79. The firm has a 50 day simple moving average of $274.96 and a 200-day simple moving average of $269.99.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business earned $2.56 EPS. On average, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CME. Citigroup lifted their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Oppenheimer raised their price target on shares of CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a report on Thursday, July 24th. Piper Sandler raised their price target on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a report on Tuesday, July 15th. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Barclays set a $298.00 target price on CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $261.93.

Read Our Latest Stock Analysis on CME

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.